Collegium Pharmaceutical Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 12:18:37 ET
More on Collegium Pharmaceutical
- Collegium Pharmaceutical: Buying The Projected Growth For 2026
- Collegium Pharmaceutical, Inc. (COLL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
- Collegium Pharmaceutical issues 2026 revenue guidance in line with estimates
- Seeking Alpha’s Quant Rating on Collegium Pharmaceutical
- Historical earnings data for Collegium Pharmaceutical
Read the full article on Seeking Alpha
For further details see:
Collegium Pharmaceutical Q4 2025 Earnings Preview
Collegium Pharmaceutical Inc.
NASDAQ: COLL
COLL Trading
0.03% G/L:
$37.21 Last:
82,716 Volume:
$37.24 Open:
COLL Latest News
COLL Stock Data
$1,476,390,634
30,817,541
0.71%
106
N/A
Pharmaceuticals
Healthcare
US
Stoughton
